Heartburn drug could ease painful sun sensitivity
NCT ID NCT05020184
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This Phase 2 trial tested whether oral cimetidine (Tagamet), a common heartburn drug, can reduce light sensitivity in people with erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP). These genetic conditions cause severe pain from sunlight exposure. The study enrolled 26 participants who took cimetidine or a placebo twice daily for several weeks. Researchers measured changes in protoporphyrin levels, time to pain symptoms in sunlight, and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cimetidine (Tagamet)
What this could lead to
If it works, this could point toward a treatment to reduce painful light sensitivity in people with protoporphyria.
What could go wrong
This is a small Phase 2 trial with only 26 participants, so results may not apply to everyone. The drug may not lower protoporphyrin levels enough to improve symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ERYTHROPOIETIC PROTOPORPHYRIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atrium Health Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, 27157, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
University of Texas Medical Branch
Galveston, Texas, 77555, United States